immune checkpoint inhibitor therapy for locally advanced and early-stage esophageal/gej cancer
Published 3 years ago • 321 plays • Length 59:11Download video MP4
Download video MP3
Similar videos
-
1:04:22
immunotherapy management of early and advanced gastric, esophageal, gej, and colorectal cancers
-
59:58
management of esophageal/gej cancers: an interdisciplinary tumor board on adjuvant immunotherapy
-
1:04:49
navigating multidisciplinary care with immunotherapy in esophageal/gej cancer
-
1:31:24
checkpoint inhibition in gi cancers: recent advances in gastric, esophageal, and crc
-
59:06
gastric and gej cancers: treatment planning and sequencing in the era of immunotherapy
-
1:29:06
leveraging neoadjuvant and adjuvant immunotherapy to improve outcomes in early-stage cancers
-
47:55
advanced gastroesophageal cancers: maximizing the benefits of novel immunotherapy approaches
-
56:48
immunotherapy for gastroesophageal cancer
-
1:35:13
catalysts for change in gastric & gej cancer
-
18:59
controversy debate 2: selecting optimal treatments for esophagus cancer - whom to operate upon?
-
1:26:59
progress in immunotherapy biomarker testing and pathologic response assessment in solid tumors
-
26:32
standard and alternative dosing regimens of immunotherapies and combinations in modern oncology
-
33:06
maximizing the of potential current and emerging immunotherapies in advanced endometrial cancer
-
1:31:16
pathologic response after neoadjuvant immunotherapy: facilitating progress in early-stage cancers
-
1:07:28
drs. kelly & molena discuss new esophageal updates: https://bit.ly/2021-esophageal
-
20:21
check-point inhibitors in esophageal and gastric cancer: when and for whom?
-
0:50
cancer breakthrough! immune checkpoint inhibitor
-
1:38:56
taking aim at gi cancers with personalized her2 and other molecularly targeted therapies
-
1:05
limitations in immune checkpoint inhibitors in treating gastric cancer